Your browser doesn't support javascript.
loading
Clinical impact of smoking on atrial fibrillation recurrence after pulmonary vein isolation.
Giomi, Andrea; Bernardini, Andrea; Perini, Alessandro Paoletti; Ciliberti, Davide; Zaccaria, Cristiano Salvatore; Signorini, Umberto; Padeletti, Margherita; Milli, Massimo.
Afiliação
  • Giomi A; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy.
  • Bernardini A; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Italy. Electronic address: andrea.bernardini@uslcentro.toscana.it.
  • Perini AP; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy.
  • Ciliberti D; Department of Experimental and Clinical Medicine, University of Florence, Italy.
  • Zaccaria CS; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Italy.
  • Signorini U; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy.
  • Padeletti M; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy.
  • Milli M; Cardiology and Electrophysiology Unit, Department of Medical Specialties, Azienda USL Toscana Centro, Santa Maria Nuova Hospital, Florence, Italy.
Int J Cardiol ; 413: 132342, 2024 Jul 04.
Article em En | MEDLINE | ID: mdl-38971534
ABSTRACT

BACKGROUND:

The clinical impact of smoking on atrial fibrillation (AF) recurrences after pulmonary vein isolation (PVI) have contradictory results in previous studies, performed on Asian populations. METHODS AND

AIM:

Smoking habit and other cardiovascular risk-factors were assessed in patients who underwent their first radiofrequency PVI for symptomatic AF. The study aims to assess the clinical impact of smoking on AF recurrences after PVI in a contemporary European cohort of patients.

RESULTS:

The study included 186 consecutive patients (135 males [72.6%]) with a mean age of 63.4 ± 9.7 years. Current smokers resulted 29 (15.7%). No statistically significant baseline differences were detected between current smokers and non-current smokers. After a follow-up of 418 ± 246 days, AF recurrence was higher in currently smoking patients vs. non-currently smoker patients, the latter intended as a combination between previous smokers and never smokers (34.5% vs. 14% p = 0.01). A previous smoking habit was not associated with increased risk of AF recurrence when compared with patients who never smoked (13.2% vs. 14.6%, p = 0.23), while a current smoking habit impacted on AF recurrence in comparison with previous smokers (p = 0.01) and never smokers (p = 0.04). The increased incidence of AF recurrence in current smokers was consistent also considering only paroxysmal AF (31.4% vs 9.6%, p = 0.012) or persistent AF (50% vs 31.2%, p = 0.03). Smoking (HR =2.96 95% CI 1.32-6.64) and persistent AF (HR =2.64 95% CI 1.22-5.7) resulted independent predictors of AF recurrence.

CONCLUSION:

Cigarette smoking is associated with an increased risk of AF recurrences after PVI, both in paroxysmal and in persistent AF.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália